International Guideline Harmonization Group
  • Home
  • About IGHG
    • Members
      • Core group
      • Guideline panels
        • Breast cancer
        • Cardiomyopathy
        • Premature ovarian insufficiency
        • Male gonadotoxicity
        • Thyroid cancer
        • Ototoxicty
        • Obstetric care
        • Central nervous system neoplasms
        • Fatigue, mental health and psychosocial problems
        • Fertility preservation
        • Hypothalamic-pituitary dysfunction
        • Coronary artery disease
        • Metabolic syndrome
        • Pulmonary dysfunction
        • Bone toxicity
        • Hepatic toxicity
        • Nephrotoxicity
        • Neurocognitive problems
        • Colorectal cancer
        • Thyroid dysfunction
    • Collaborators
    • Funding sources
    • Methods
      • Process
      • Grading system
      • Topic selection
      • Publication
      • Handbook
  • Guidelines
    • Topics
      • Breast cancer
        • Recommendations
        • Conclusions of evidence
        • Evidence tables
        • Publication
        • Guideline panel
      • Cardiomyopathy
        • Recommendations
        • Conclusions of evidence
        • Evidence tables
        • Publication
        • Guideline panel
      • Premature ovarian insufficiency
        • Recommendations
        • Conclusions of evidence
        • Evidence tables
        • Publication
        • Guideline panel
      • Male gonadotoxicity
        • Recommendations
        • Conclusions of evidence
        • Evidence tables
        • Publication
        • Guideline panel
      • Thyroid cancer
        • Recommendations
        • Conclusions of evidence
        • Evidence tables
        • Publication
        • Guideline panel
      • Ototoxicity
        • Recommendations
        • Conclusions of evidence
        • Evidence tables
        • Publication
        • Guideline panel
      • Obstetric care
        • Recommendations
        • Conclusions of evidence
        • Evidence tables
        • Publication
        • Guideline panel
      • Central nervous system neoplasms
        • Guideline panel
      • Fatigue
        • Recommendations
        • Conclusions of evidence
        • Evidence tables
        • Publication
        • Guideline panel
      • Psychosocial problems
        • Guideline panel
      • Mental health problems
        • Guideline panel
      • Fertility preservation
        • Recommendations
        • Conclusions of evidence
        • Evidence tables
        • Publications
        • Guideline panel
      • Hypothalamic-pituitary dysfunction
        • Guideline panel
      • Coronary artery disease
        • Guideline panel
      • Metabolic syndrome
        • Guideline panel
      • Pulmonary dysfunction
        • Guideline panel
      • Bone toxicity
        • Guideline panel
      • Hepatic toxicity
        • Guideline panel
      • Nephrotoxicity
        • Guideline panel
      • Colorectal cancer
        • Guideline panel
      • Neurocognitive problems
        • Guideline panel
      • Thyroid dysfunction
        • Guideline panel
  • Patient education
  • News
  • Meetings
  • Contact

Male gonadotoxicity

Home Guidelines Topics Male gonadotoxicity Conclusions of evidence

  • Topics
    • Breast cancer
      • Recommendations
      • Conclusions of evidence
      • Evidence tables
      • Publication
      • Guideline panel
    • Cardiomyopathy
      • Recommendations
      • Conclusions of evidence
      • Evidence tables
      • Publication
      • Guideline panel
    • Premature ovarian insufficiency
      • Recommendations
      • Conclusions of evidence
      • Evidence tables
      • Publication
      • Guideline panel
    • Male gonadotoxicity
      • Recommendations
      • Conclusions of evidence
      • Evidence tables
      • Publication
      • Guideline panel
    • Thyroid cancer
      • Recommendations
      • Conclusions of evidence
      • Evidence tables
      • Publication
      • Guideline panel
    • Ototoxicity
      • Recommendations
      • Conclusions of evidence
      • Evidence tables
      • Publication
      • Guideline panel
    • Obstetric care
      • Recommendations
      • Conclusions of evidence
      • Evidence tables
      • Publication
      • Guideline panel
    • Central nervous system neoplasms
      • Guideline panel
    • Fatigue
      • Recommendations
      • Conclusions of evidence
      • Evidence tables
      • Publication
      • Guideline panel
    • Psychosocial problems
      • Guideline panel
    • Mental health problems
      • Guideline panel
    • Fertility preservation
      • Recommendations
      • Conclusions of evidence
      • Evidence tables
      • Publications
      • Guideline panel
    • Hypothalamic-pituitary dysfunction
      • Guideline panel
    • Coronary artery disease
      • Guideline panel
    • Metabolic syndrome
      • Guideline panel
    • Pulmonary dysfunction
      • Guideline panel
    • Bone toxicity
      • Guideline panel
    • Hepatic toxicity
      • Guideline panel
    • Nephrotoxicity
      • Guideline panel
    • Colorectal cancer
      • Guideline panel
    • Neurocognitive problems
      • Guideline panel
    • Thyroid dysfunction
      • Guideline panel

Conclusions of evidence

The conclusions and levels of evidence of gonadotoxicity surveillance for male childhood, adolescent and young adult cancer survivors are presented in the following documents:

Conclusions and levels of evidence male gonadotoxicity surveillance

Conclusions of evidence tables from systematic search male gonadotoxicity surveillance

Summary of evidence from the supplemental literature search male gonadotoxicity surveillance

See The Lancet Oncology for the publication.

  • Contact
  • Disclaimer

© International Guideline Harmonization Group